| Blood pressure control and factors predicting control in a treatment-compliant male veteran population. | |
| | |
MedLine Citation:
|
PMID: 14998218 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
STUDY OBJECTIVE: To estimate blood pressure control and identify treatment variables predicting control in treatment-compliant, hypertensive, male veterans. SETTING: Outpatient clinic of a Veterans Affairs medical center. DESIGN: Retrospective review of computerized patient records over a 12-month period for demographics, comorbidities, patient-specific blood pressure goals, blood pressure history, antihypertensive therapy, and refill history. PATIENTS: Two hundred fifty hypertensive men aged 39-90 years whose antihypertensive regimen remained unchanged over 12 months. MEASUREMENTS AND MAIN RESULTS: The proportion of patients with blood pressures below 160/90 mm Hg was 86%; only 34.8% had pressures below 140/90 mm Hg. Blood pressure control was less common with advancing age (42.1%, 33.7%, and 29.4% for patients aged < 60, 60-75, and > 75 yrs, respectively, p = 0.057 for trend). Treatment intensity was highest in obese men, those aged 60-75 years, and those with a history of chronic heart failure or angina, and lowest in men older than 75 years or with a history of stroke. Blood pressure control was independently associated with therapy with beta-blockers (odds ratio [OR] 3.5, 95% confidence interval [CI] 1.5-10.2, p = 0.005), loop diuretics (OR 4.3, 95% CI 1.6-12.1, p = 0.005), angiotensin-converting enzyme inhibitors (OR 3.1, 95% CI 1.2-8.2, p = 0.025), and long-term simvastatin therapy (OR 3.7, 95% CI 1.9-7.4, p = 0.0001), and with a diagnosis of coronary artery disease (OR 3.2, 95% CI 1.35-7.69, p = 0.009). The relationship between simvastatin therapy and blood pressure control persisted after controlling for the higher treatment intensity in patients taking the drug. Factors predicting poor control included a history of stroke (OR for control 0.36, 95% CI 0.19-0.69, p = 0.002), age over 75 years (OR 0.43, 95% CI 0.18-0.98, p = 0.046), highest low-density lipoprotein tertile (OR 0.37, 95% CI 0.17-0.80, p = 0.013), highest body mass index tertile (OR 0.46, 95% CI 0.21-1.00, p = 0.05), and therapy with two or fewer antihypertensives (OR 0.14, 95% CI 0.04-0.61, p = 0.009). CONCLUSION: In a compliant veteran population, control of blood pressure appeared inadequate but was significantly more likely in those receiving at least three antihypertensive agents. Long-term therapy with simvastatin was independently associated with increased odds of control. |
| | |
Authors:
|
Marcel D Bizien; Sandra G Jue; Chad Panning; Barry Cusack; Teri Peterson |
Related Documents
:
|
6848458 - Hypothyroidism as a cause of hypertension. 2977328 - Autogenic training in the treatment and secondary prevention of essential hypertension:... 17967968 - Impact of human factor design on the use of order sets in the treatment of congestive h... 16157788 - Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, ... 6085358 - Comparison of the acute hemodynamic effects of nifedipine with nitrendipine and a study... 6499548 - Arterial oxygen desaturation following salbutamol inhalation in acute asthma. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pharmacotherapy Volume: 24 ISSN: 0277-0008 ISO Abbreviation: Pharmacotherapy Publication Date: 2004 Feb |
Date Detail:
|
Created Date: 2004-03-04 Completed Date: 2004-07-28 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8111305 Medline TA: Pharmacotherapy Country: United States |
Other Details:
|
Languages: eng Pagination: 179-87 Citation Subset: IM |
Affiliation:
|
Ambulatory Care Pharmacy Services, Mayo Clinic, Rochester, Minnesota 55905, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Blood Pressure / drug effects*, physiology* Comorbidity Demography Humans Hypertension / drug therapy, prevention & control* Male Middle Aged Patient Care Planning* Patient Compliance* Prognosis Retrospective Studies Risk Factors Simvastatin / therapeutic use Treatment Outcome Veterans* |
| Chemical | |
Reg. No./Substance:
|
79902-63-9/Simvastatin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of a critical pathway on acute myocardial infarction quality indicators.
Next Document: Determination of the lack of a drug interaction between azithromycin and warfarin.